Dividend Dilemma: Realty Income or Pfizer?

Two titans of the dividend arena, Realty Income (O) and Pfizer (PFE), stand before us. Both have long histories of distributing dividends, though their paths diverge like those of two men at a crossroads-one with a map, the other with a compass.

Why Walmart Could Be Warren Buffett’s Hidden Gem in 2025

Walmart is, of course, a familiar name in Buffett’s portfolio-a dalliance that began in 2005 and, like most of his romantic entanglements, ended with a certain sense of disillusionment in 2018. For over a decade, Walmart was a principal figure in Berkshire Hathaway’s empire, only for Buffett to begin shedding the stock in 2015, his faith eroded by the siren call of Amazon’s e-commerce juggernaut. In fact, shortly after bidding farewell to Walmart, Buffett turned to Amazon, buying up shares with the same fervor as a lovesick teenager.

Warren Buffett’s 95th Birthday: Lessons in Longevity & Wealth

Royston Yang: Before Buffett, I was the investing equivalent of a TikTok stock tipper-buying based on vibes and a Google search. Then the Oracle of Omaha dropped a mic drop on my ignorance: Stocks aren’t *things*; they’re *businesses*. Suddenly, I wasn’t just picking winners; I was dating companies. It was like swiping right on a soulmate… who also pays rent on time. Happy birthday to the guy who made me stop sounding like a broke college student in a Reddit thread.

20 One-Hit-Wonder Actors Defined by Their Iconic Role

This compilation explores actors who have become synonymous with a specific iconic character. For each actor, it highlights what made their role stand out, followed by an account of their subsequent career moves, be it further acting roles, theater work, or even a shift into a completely different profession.

SoFi Stock: A Fever Dream of Greed and Growth

SoFi has been on a rampage lately, devouring markets and spitting out profits like a rabid wolf tearing through a flock of sheep. Over the past three years, its share price has skyrocketed more than 300%, making early investors feel like they’ve cracked the cosmic code. But here we are, staring at $30 as if it’s the edge of a cliff, wondering whether jumping off will send us soaring-or plummeting into the abyss.

Three Stocks for the Discerning Investor’s Portfolio

Alphabet (GOOG) (GOOGL) reigns as a colossus of the digital realm, its empire built on the twin pillars of Google Search and the ever-expanding Google Cloud. Critics whisper of generative AI as a storm in the distance, a threat to displace the old guard. But let us not mistake the horizon for a battlefield. Google Search, that “old-world” sentinel, still commands the field with a dominance honed over decades. Even as it weaves generative AI into its fabric-a union of machine and man-the algorithm’s pulse remains steady, its revenue rising 12% in Q2 alone.

Marlon Brando’s Best Roles

Over the course of his lengthy and sometimes stormy acting career, Marlon Brando crafted an indelible collection of iconic characters that continue to resonate in cinema history. Ranging from explosive anti-heroes to commanding patriarchs, Brando’s knack for immersing himself completely into a role was nothing short of legendary. He broke norms, confounded assumptions, and left behind a timeless legacy that inspires actors globally, cementing his position as one of the greatest performers ever to captivate moviegoers.

IonQ’s Quantum Leap: A Contrarian’s Guide to the Galaxy

The biggest reason I think IonQ can soar over the next few years is its quantum computing approach, which is less cost-intensive than that of some of its competitors. Because it could be cheaper to deploy and scale, it could give IonQ a massive advantage over its competitors, allowing it to capture a market that IonQ estimates could be worth $87 billion by 2035. (This is the same logic that convinced the ancient Greeks to build a wooden horse, which, incidentally, also had a 200% return on investment-until it didn’t.)

Meta’s AI Gambit: A Wealth Builder’s Perspective

Meta, you see, has already secured its quarry: a veritable menagerie of luminaries from the rarefied world of AI research, lured by offers so opulent they would make Midas blush. Nine-figure bonuses, whispered like incantations in the corridors of Silicon Valley, were but the bait. Now, having ensnared these prodigies, Meta pauses-not out of despair, but discernment. It is reorganizing, aligning its newly acquired talent with projects worthy of their genius. One such division, cryptically named “TBD Lab,” hints at mysteries yet undreamt, a blank canvas awaiting the brushstrokes of brilliance.